Skip to content
lifestyle.chroniccities.us
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Synklino
Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation
May 28, 2026
Synklino announces publication in American Journal of Transplantation highlighting proof-of-concept for SYN002 in eliminating CMV in human kidneys
February 25, 2026